Literature DB >> 11181052

Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts.

E Hinoi1, S Fujimori, Y Nakamura, Y Yoneda.   

Abstract

Reverse transcription polymerase chain reaction revealed expression of mRNAs for particular receptors for the central neurotransmitter l-glutamic acid (Glu) in primary cultures of rat calvarial osteoblastic cells under premature to mature states according to the duration of days in vitro. These included metabotropic Glu receptors (mGluR) such as mGluR4 and mGluR8, in addition to several ionotropic Glu receptor subunits including NR1 and NR2D. Expression of mRNAs was not detected with other mGluR and NR2A-C subunits irrespective of the maturity of cultured cells. The agonist for group III mGluR L-(+)-2-amino-4-phosphonobutyric acid significantly inhibited the forskolin-induced accumulation of cAMP in premature osteoblasts, which occurred in a manner sensitive to prevention by the group III mGluR antagonist (RS)-alpha-cyclopropyl-4-phosphonophenylglycine. These results suggest that Glu may at least in part play a role in mechanisms associated with cellular proliferation and/or differentiation through group III mGluR functionally expressed in rat calvarial osteoblastic cells. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181052     DOI: 10.1006/bbrc.2001.4355

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Multiple signaling pathways involved in stimulation of osteoblast differentiation by N-methyl-D-aspartate receptors activation in vitro.

Authors:  Jie-li Li; Lin Zhao; Bin Cui; Lian-fu Deng; Guang Ning; Jian-min Liu
Journal:  Acta Pharmacol Sin       Date:  2011-06-20       Impact factor: 6.150

2.  Abolition of chondral mineralization by group III metabotropic glutamate receptors expressed in rodent cartilage.

Authors:  Liyang Wang; Eiichi Hinoi; Akihiro Takemori; Takeshi Takarada; Yukio Yoneda
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

3.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

4.  Secretion of L-glutamate from osteoclasts through transcytosis.

Authors:  Riyo Morimoto; Shunsuke Uehara; Shouki Yatsushiro; Narinobu Juge; Zhaolin Hua; Shigenori Senoh; Noriko Echigo; Mitsuko Hayashi; Toshihide Mizoguchi; Tadashi Ninomiya; Nobuyuki Udagawa; Hiroshi Omote; Akitsugu Yamamoto; Robert H Edwards; Yoshinori Moriyama
Journal:  EMBO J       Date:  2006-09-07       Impact factor: 11.598

5.  Glutamate suppresses osteoclastogenesis through the cystine/glutamate antiporter.

Authors:  Eiichi Hinoi; Takeshi Takarada; Kyosuke Uno; Maki Inoue; Yasuhiro Murafuji; Yukio Yoneda
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

Review 6.  Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders.

Authors:  Kimberly R Byrnes; David J Loane; Alan I Faden
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

7.  Positive regulation by GABA(B)R1 subunit of leptin expression through gene transactivation in adipocytes.

Authors:  Yukari Nakamura; Eiichi Hinoi; Takeshi Takarada; Yoshifumi Takahata; Tomomi Yamamoto; Hiroyuki Fujita; Saya Takada; Syota Hashizume; Yukio Yoneda
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

8.  Improved biocompatibility of novel poly(L-lactic acid)/β-tricalcium phosphate scaffolds prepared by an organic solvent-free method.

Authors:  Xue-feng Zhao; Xiao-dong Li; Yun-qing Kang; Quan Yuan
Journal:  Int J Nanomedicine       Date:  2011-07-04

9.  Glutamate signaling in healthy and diseased bone.

Authors:  Robert W Cowan; Eric P Seidlitz; Gurmit Singh
Journal:  Front Endocrinol (Lausanne)       Date:  2012-07-19       Impact factor: 5.555

10.  Glutamate signaling in bone.

Authors:  Karen S Brakspear; Deborah J Mason
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.